Related Experiment Video
Updated: Apr 19, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
New insights on the mechanism of quinoline-based DNA Methyltransferase inhibitors
Christina Gros1, Laurence Fleury1, Virginie Nahoum2
1From the Unité de Service et de Recherche CNRS-Pierre Fabre 3388, ETaC, CRDPF, 31100 Toulouse, France.
Abstract:
Among the epigenetic marks, DNA methylation is one of the most studied. It is highly deregulated in numerous diseases, including cancer. Indeed, it has been shown that hypermethylation of tumor suppressor genes promoters is a common feature of cancer cells. Because DNA methylation is reversible, the DNA methyltransferases (DNMTs), responsible for this epigenetic mark, are considered promising therapeutic targets. Several molecules have been identified as DNMT inhibitors and, among the non-nucleoside inhibitors, 4-aminoquinoline-based inhibitors, such as SGI-1027 and its analogs, showed potent inhibitory activity. Here we characterized the in vitro mechanism of action of SGI-1027 and two analogs. Enzymatic competition studies with the DNA substrate and the methyl donor cofactor, S-adenosyl-l-methionine (AdoMet), displayed AdoMet non-competitive and DNA competitive behavior. In addition, deviations from the Michaelis-Menten model in DNA competition experiments suggested an interaction with DNA. Thus their ability to interact with DNA was established; although SGI-1027 was a weak DNA ligand, analog 5, the most potent inhibitor, strongly interacted with DNA. Finally, as 5 interacted with DNMT only when the DNA duplex was present, we hypothesize that this class of chemical compounds inhibit DNMTs by interacting with the DNA substrate.
Insights
DNA methyltransferases (DNMTs) are key targets in cancer therapy. SGI-1027 analogs inhibit DNMTs by interacting with DNA, not directly with the enzyme.
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Research
Background:
- DNA methylation is a critical epigenetic mark frequently altered in cancer.
- DNA methyltransferases (DNMTs) are responsible for DNA methylation and are promising therapeutic targets.
- 4-aminoquinoline derivatives, like SGI-1027, show potent DNMT inhibitory activity.
Purpose of the Study:
- To elucidate the in vitro mechanism of action of SGI-1027 and two analogs.
- To investigate the interaction of these compounds with DNA methyltransferases (DNMTs) and their substrates.
- To determine if inhibition involves direct enzyme interaction or DNA binding.
Main Methods:
- Enzymatic competition assays using DNA substrate and S-adenosyl-l-methionine (AdoMet).
- Michaelis-Menten kinetics analysis to assess enzyme inhibition patterns.
- DNA binding affinity studies for SGI-1027 and its analogs.
Main Results:
- SGI-1027 and analogs exhibited non-competitive behavior with AdoMet and competitive behavior with the DNA substrate.
- Deviations from Michaelis-Menten kinetics indicated DNA interaction.
- Analog 5, the most potent inhibitor, showed strong DNA binding, while SGI-1027 was a weak DNA ligand.
- Analog 5 interacted with DNMTs only in the presence of the DNA duplex.
Conclusions:
- The 4-aminoquinoline-based DNMT inhibitors, particularly analog 5, likely function by interacting with the DNA substrate.
- This DNA-centric inhibition mechanism offers a novel therapeutic strategy for targeting aberrant DNA methylation in diseases like cancer.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...

